Neisseria gonorrhoeae Binx Health Chlamydia and Gonorrhea Test CLIA Waived The 30-minute test can be used on samples from males and females in settings operating under a CLIA certificate of waiver. Visby Medical Takes on STI, COVID-19 Testing With Single-Use PCR Machine Premium The company is currently working on multiple infectious disease products, including a panel for sexually transmitted infections and one for SARS-CoV-2. Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition The PCR diagnostic device is a palm-size, single-use, disposable device that detects N. gonorrhoeae and determines if it's susceptible to an antibiotic. New York State Approves Enzo Biochem STI Tests on GenFlex Platform The GenFlex is a sample-to-result molecular diagnostic platform that includes sample collection, processing, amplification, and detection, the company said. Rheonix Submits MDx System, Triplex Sexually Transmitted Infections Test to FDA The Ithaca, New York-based firm has submitted its molecular diagnostic instrument along with a test to detect chlamydia, gonorrhea, and trichomonas. Nov 7, 2019 SpeeDx, QuantuMDx Collaborate with FIND on POC Molecular Diagnostics for STIs Nov 4, 2019 Shield Bio Brings Nanopore Sequencing to Patients Through STI Test Service Premium Sep 6, 2019 As M. Genitalium, Gonorrhea Molecular Testing Expands, Antibiotic Resistance Assays May Follow Premium Jul 11, 2019 Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models Sep 4, 2014 UCLA Lab Wins NIH Funds to Validate Gonorrhea 'Superbug' Test Premium Apr 10, 2014 Dx Focus: Cepheid Xpert Norovirus; BD Max GC rt PCR Assay Premium Dec 5, 2013 Dx Focus: BD Max StaphSR Assay; Roche Cobas CT/NG v2.0 Test Premium Dec 4, 2013 Roche Gets FDA OK for Four Specimen Types in CT/NG Testing Mar 14, 2013 On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study Premium Dec 28, 2012 FDA Clears Cepheid's Xpert CT/NG Test Nov 13, 2012 PerkinElmer Dives Into Chinese MDx Market with Shanghai Haoyuan Acquisition Jun 14, 2012 Team Developing Network Biosystems MDx Platform for Biothreat Testing Under Five-Year NIH Grant Premium Aug 18, 2011 Dutch Firm PathoFinder's Multiplex STD Assay Performs Well in Comparative Study Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.